Novel compound combats drug-resistant fungi when combined with commercially available medications

A study conducted at the University of São Paulo (USP) in Brazil shows that brilacidin, a new drug tested for treatment of diseases ranging from bacterial skin infections to COVID-19, can kill drug-resistant strains of fungi when combined with two classes of anti-fungals available on the market.

Leave A Comment

Your email address will not be published. Required fields are marked *